CYBRD1 and breast cancer: However, we observed that DCYTB expression increased in molecular subtypes with more favorable prognosis (Fig. 3 and Additional file 1: Figure S5), demonstrating that as a prognostic marker, DCYTB exhibits behavior that mimics known molecular markers of breast cancer.